Theeranun Sanpajit

A phase I/II study of foretinib, an oral multikinase inhibitor targeting MET, RON, AXL, TIE-2, and VEGFR in advanced hepatocellular carcinoma (HCC).

R. Lencioni, Pei-Jer Chen, T. Yau, 2012 .

Treatment outcomes and validation of the stopping rule for response to peginterferon in chronic hepatitis B: A Thai nationwide cohort study

P. Komolmit, C. Bunchorntavakul, T. Tanwandee, 2016, Journal of gastroenterology and hepatology.

Comparison of normal saline versus Lactated Ringer's solution for fluid resuscitation in patients with mild acute pancreatitis, A randomized controlled trial.

Sakkarin Chirapongsathorn, Wanich Piyanirun, Theeranun Sanpajit, 2018, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

813 – Curcuma Longa Linn Versus Omeprazole in Treatment of Functional Dyspepsia, a Randomized, Double-Blind, Placebo-Controlled Trial

Sakkarin Chirapongsathorn, Wanich Piyanirun, Kachonsak Yongwatana, 2019, Gastroenterology.

A Phase I/II Multicenter Study of Single-Agent Foretinib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma

R. Lencioni, T. Yau, Y. Chao, 2016, Clinical Cancer Research.

Association of the S267F Variant on NTCP Gene and Treatment Response to Pegylated Interferon in Patients with Chronic Hepatitis B: A Multicentre Study

P. Komolmit, C. Bunchorntavakul, Y. Poovorawan, 2018, Antiviral therapy.

Real-world effectiveness and safety of sofosbuvir and nonstructural protein 5A inhibitors for chronic hepatitis C genotype 1, 2, 3, 4, or 6: a multicentre cohort study

P. Komolmit, P. Tangkijvanich, C. Bunchorntavakul, 2020, BMC Gastroenterology.

Curcuma longa Linn versus omeprazole in treatment of functional dyspepsia: A randomized, double‐blind, placebo‐controlled trial

Sakkarin Chirapongsathorn, Wanich Piyanirun, Kachonsak Yongwatana, 2021, Journal of gastroenterology and hepatology.